ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 154 filers reported holding ACORDA THERAPEUTICS INC in Q1 2014. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $186,000 | -30.6% | 362,581 | -0.6% | 0.00% | – |
| Q2 2020 | $268,000 | -55.6% | 364,908 | -43.6% | 0.00% | – |
| Q1 2020 | $603,000 | -78.6% | 646,672 | -53.2% | 0.00% | – |
| Q4 2019 | $2,816,000 | +74.3% | 1,381,358 | +145.3% | 0.00% | – |
| Q3 2019 | $1,616,000 | -66.9% | 563,180 | -11.7% | 0.00% | -100.0% |
| Q2 2019 | $4,889,000 | -35.7% | 637,607 | +11.4% | 0.00% | -50.0% |
| Q1 2019 | $7,606,000 | -54.7% | 572,366 | -46.9% | 0.00% | -33.3% |
| Q4 2018 | $16,792,000 | +55.1% | 1,077,954 | +95.6% | 0.00% | 0.0% |
| Q3 2018 | $10,828,000 | -24.7% | 551,093 | +10.0% | 0.00% | -25.0% |
| Q2 2018 | $14,375,000 | +45.1% | 500,900 | +19.5% | 0.00% | +33.3% |
| Q1 2018 | $9,910,000 | +12.7% | 419,067 | +2.2% | 0.00% | 0.0% |
| Q4 2017 | $8,795,000 | -13.7% | 410,068 | -4.8% | 0.00% | -25.0% |
| Q3 2017 | $10,191,000 | +13.9% | 430,928 | -5.1% | 0.00% | 0.0% |
| Q2 2017 | $8,946,000 | -3.3% | 454,145 | +3.0% | 0.00% | 0.0% |
| Q1 2017 | $9,256,000 | +20.8% | 440,824 | +8.1% | 0.00% | 0.0% |
| Q4 2016 | $7,665,000 | -4.2% | 407,794 | +6.4% | 0.00% | 0.0% |
| Q3 2016 | $8,003,000 | -13.4% | 383,350 | +5.8% | 0.00% | -20.0% |
| Q2 2016 | $9,245,000 | -1.8% | 362,496 | +1.8% | 0.01% | 0.0% |
| Q1 2016 | $9,415,000 | -30.1% | 355,981 | +13.0% | 0.01% | -37.5% |
| Q4 2015 | $13,475,000 | +72.4% | 314,997 | +6.9% | 0.01% | +60.0% |
| Q3 2015 | $7,814,000 | -19.6% | 294,777 | +1.1% | 0.01% | -16.7% |
| Q2 2015 | $9,718,000 | +9.3% | 291,571 | +9.2% | 0.01% | +20.0% |
| Q1 2015 | $8,888,000 | -23.1% | 267,075 | -5.5% | 0.01% | -28.6% |
| Q4 2014 | $11,556,000 | +22.2% | 282,758 | +1.3% | 0.01% | +16.7% |
| Q3 2014 | $9,459,000 | +8.3% | 279,211 | +7.8% | 0.01% | 0.0% |
| Q2 2014 | $8,733,000 | +4.4% | 259,091 | +17.4% | 0.01% | 0.0% |
| Q1 2014 | $8,363,000 | +38.9% | 220,625 | +7.0% | 0.01% | +50.0% |
| Q4 2013 | $6,020,000 | -5.4% | 206,171 | +11.0% | 0.00% | -20.0% |
| Q3 2013 | $6,367,000 | +11.0% | 185,736 | +6.9% | 0.01% | 0.0% |
| Q2 2013 | $5,734,000 | – | 173,802 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 325,000 | $8,289,000 | 2.39% |
| ARMISTICE CAPITAL, LLC | 232,000 | $5,917,000 | 2.25% |
| SENZAR ASSET MANAGEMENT, LLC | 358,191 | $9,135,662,000 | 1.99% |
| SCOPIA CAPITAL MANAGEMENT LP | 3,171,229 | $80,882,000 | 1.67% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,029,410 | $26,255,000 | 1.03% |
| Baker Brothers Advisors | 3,661,082 | $93,376,000 | 0.98% |
| ARBOR CAPITAL MANAGEMENT LLC | 58,783 | $1,499,000 | 0.79% |
| Spark Investment Management LLC | 292,400 | $7,457,000 | 0.70% |
| SPHERA FUNDS MANAGEMENT LTD. | 98,000 | $2,499,000 | 0.65% |
| Virtus ETF Advisers LLC | 21,130 | $539,000 | 0.40% |